Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Genocea Biosciences Inc. (OTC : GNCAQ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns a pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.
Quote
| Last: | $0.0001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0001 |
| Close: | $0.0001 |
| High: | $0.0001 |
| Low: | $0.0001 |
| Volume: | 156 |
| Last Trade Date Time: | 05/22/2026 10:59:08 am |
Stock Data
| Market Cap: | $59 |
|---|---|
| Float: | 57,837,089 |
| Insiders Ownership: | 1.4% |
| Institutions: | 30 |
| Short Percent: | 1637397% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.genocea.com |
| Country: | US |
| City: | Cambridge |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
investorshub : Renee
investorshub : MVick
investorshub : swampboots
investorshub : jondoeuk
**MWN-AI FAQ is based on asking OpenAI questions about Genocea Biosciences Inc. (OTC: GNCAQ).
